General Information of Drug Off-Target (DOT) (ID: OT13LE5J)

DOT Name T-cell surface glycoprotein CD3 epsilon chain (CD3E)
Synonyms T-cell surface antigen T3/Leu-4 epsilon chain; CD antigen CD3e
Gene Name CD3E
Related Disease
Immunodeficiency 18 ( )
T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta ( )
UniProt ID
CD3E_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
1A81; 1SY6; 1XIW; 2ROL; 5QU2; 6JXR; 7FJD; 7FJE; 7FJF; 7PHR; 8ES7; 8ES8; 8ES9; 8F0L
Pfam ID
PF16681 ; PF02189
Sequence
MQSGTHWRVLGLCLLSVGVWGQDGNEEMGGITQTPYKVSISGTTVILTCPQYPGSEILWQ
HNDKNIGGDEDDKNIGSDEDHLSLKEFSELEQSGYYVCYPRGSKPEDANFYLYLRARVCE
NCMEMDVMSVATIVIVDICITGGLLLLVYYWSKNRKAKAKPVTRGAGAGGRQRGQNKERP
PPVPNPDYEPIRKGQRDLYSGLNQRRI
Function
Part of the TCR-CD3 complex present on T-lymphocyte cell surface that plays an essential role in adaptive immune response. When antigen presenting cells (APCs) activate T-cell receptor (TCR), TCR-mediated signals are transmitted across the cell membrane by the CD3 chains CD3D, CD3E, CD3G and CD3Z. All CD3 chains contain immunoreceptor tyrosine-based activation motifs (ITAMs) in their cytoplasmic domain. Upon TCR engagement, these motifs become phosphorylated by Src family protein tyrosine kinases LCK and FYN, resulting in the activation of downstream signaling pathways. In addition of this role of signal transduction in T-cell activation, CD3E plays an essential role in correct T-cell development. Initiates the TCR-CD3 complex assembly by forming the two heterodimers CD3D/CD3E and CD3G/CD3E. Participates also in internalization and cell surface down-regulation of TCR-CD3 complexes via endocytosis sequences present in CD3E cytosolic region.
KEGG Pathway
Hematopoietic cell lineage (hsa04640 )
Th1 and Th2 cell differentiation (hsa04658 )
Th17 cell differentiation (hsa04659 )
T cell receptor sig.ling pathway (hsa04660 )
Chagas disease (hsa05142 )
Measles (hsa05162 )
Human T-cell leukemia virus 1 infection (hsa05166 )
Epstein-Barr virus infection (hsa05169 )
Human immunodeficiency virus 1 infection (hsa05170 )
PD-L1 expression and PD-1 checkpoint pathway in cancer (hsa05235 )
Primary immunodeficiency (hsa05340 )
Reactome Pathway
Downstream TCR signaling (R-HSA-202424 )
Phosphorylation of CD3 and TCR zeta chains (R-HSA-202427 )
Translocation of ZAP-70 to Immunological synapse (R-HSA-202430 )
Generation of second messenger molecules (R-HSA-202433 )
PD-1 signaling (R-HSA-389948 )
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell (R-HSA-198933 )

Molecular Interaction Atlas (MIA) of This DOT

2 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Immunodeficiency 18 DIS9LM1Z Definitive Autosomal recessive [1]
T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta DISPUD3N Supportive Autosomal recessive [2]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Arsenic DMTL2Y1 Approved Arsenic affects the methylation of T-cell surface glycoprotein CD3 epsilon chain (CD3E). [3]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of T-cell surface glycoprotein CD3 epsilon chain (CD3E). [5]
------------------------------------------------------------------------------------
3 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Amphotericin B DMTAJQE Approved Amphotericin B increases the expression of T-cell surface glycoprotein CD3 epsilon chain (CD3E). [4]
(+)-JQ1 DM1CZSJ Phase 1 (+)-JQ1 decreases the expression of T-cell surface glycoprotein CD3 epsilon chain (CD3E). [6]
GSK618334 DMJPXZ4 Phase 1 GSK618334 decreases the expression of T-cell surface glycoprotein CD3 epsilon chain (CD3E). [7]
------------------------------------------------------------------------------------

References

1 Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6.
2 Clinical Practice Guidelines for Rare Diseases: The Orphanet Database. PLoS One. 2017 Jan 18;12(1):e0170365. doi: 10.1371/journal.pone.0170365. eCollection 2017.
3 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
4 Differential expression of microRNAs and their predicted targets in renal cells exposed to amphotericin B and its complex with copper (II) ions. Toxicol Mech Methods. 2017 Sep;27(7):537-543. doi: 10.1080/15376516.2017.1333554. Epub 2017 Jun 8.
5 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
6 BET bromodomain inhibition as a novel strategy for reactivation of HIV-1. J Leukoc Biol. 2012 Dec;92(6):1147-54. doi: 10.1189/jlb.0312165. Epub 2012 Jul 16.
7 Phase IIa trial of fingolimod for amyotrophic lateral sclerosis demonstrates acceptable acute safety and tolerability. Muscle Nerve. 2017 Dec;56(6):1077-1084. doi: 10.1002/mus.25733. Epub 2017 Aug 29.